These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8792959)

  • 1. Prolonged marijuana-like dysphoria after subcutaneous sumatriptan.
    Bakshi R; Yan-Go FL
    Ann Pharmacother; 1996 Jun; 30(6):683. PubMed ID: 8792959
    [No Abstract]   [Full Text] [Related]  

  • 2. Triptans to the rescue: effective therapy for migraine headaches in the workplace.
    Bartleson JD
    Mayo Clin Proc; 2000 Aug; 75(8):780-1. PubMed ID: 10943229
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral and subcutaneous sumatriptan in the acute treatment of migraine: an open randomized cross-over study.
    Carpay HA; Matthijsse P; Steinbuch M; Mulder PG
    Cephalalgia; 1997 Aug; 17(5):591-5. PubMed ID: 9251875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin syndrome complicating migraine pharmacotherapy.
    Mathew NT; Tietjen GE; Lucker C
    Cephalalgia; 1996 Aug; 16(5):323-7. PubMed ID: 8869767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sumatriptan and naratriptan tolerability and safety: an update of post-marketing experience.
    Welch KM
    Cephalalgia; 2001; 21 Suppl 1():25-8. PubMed ID: 11678818
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug-clinics. The drug of the month. Imitrex nasal spray (sumatriptan)].
    Scheen AJ
    Rev Med Liege; 1997 Sep; 52(9):610-2. PubMed ID: 9441347
    [No Abstract]   [Full Text] [Related]  

  • 7. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
    Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V
    Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial.
    Schulman EA; Cady RK; Henry D; Batenhorst AS; Putnam DG; Watson CB; O'Quinn SO
    Mayo Clin Proc; 2000 Aug; 75(8):782-9. PubMed ID: 10943230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of high sumatriptan dosages during episodic cluster headache: three clinical cases.
    Centonze V; Polito BM; Attolini E; Cassiano MA; Sabbà C; Ricchhetti G; Bassi A; Cavazzuti L; Albano O
    Headache; 1996 Jun; 36(6):389-91. PubMed ID: 8707559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sumatriptan and panic-like symptoms.
    Loi V; Lai M; Pisano MR; Del Zompo M
    Am J Psychiatry; 1996 Nov; 153(11):1505. PubMed ID: 8890694
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation of pain by sumatriptan.
    Coulter DM; Passier JL; Clark DW; van Puijenbroek EP
    Headache; 2003 Oct; 43(9):994-9. PubMed ID: 14511277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability of sumatriptan: clinical trials and postmarketing experience.
    Allen C; Dayno J
    Cephalalgia; 2001 Oct; 21(8):855-6. PubMed ID: 11737014
    [No Abstract]   [Full Text] [Related]  

  • 13. Sumatriptan-associated ischemic colitis.
    Naik M; Potluri R; Almasri E; Arnold GL
    Dig Dis Sci; 2002 Sep; 47(9):2015-6. PubMed ID: 12353847
    [No Abstract]   [Full Text] [Related]  

  • 14. Alteration in nature of cluster headache during subcutaneous administration of sumatriptan.
    Hering-Hanit R
    Headache; 2000 Jan; 40(1):41-4. PubMed ID: 10759902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and tolerability of sumatriptan after single-dose administration of a fixed-dose combination tablet of sumatriptan/naproxen sodium 85/500 mg followed two hours later by subcutaneous sumatriptan 4- or 6-mg injection: a randomized, open-label, three-period crossover study in healthy volunteers.
    Berges A; Walls C; Lener SE; McDonald SA
    Clin Ther; 2010 Jun; 32(6):1165-77. PubMed ID: 20637969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of myocardial infarction with sumatriptan use.
    Erbilen E; Ozhan H; Akdemir R; Yazici M
    Pediatr Cardiol; 2005; 26(4):464-6. PubMed ID: 16374699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine.
    O'Quinn S; Davis RL; Gutterman DL; Pait GD; Fox AW
    Cephalalgia; 1999 May; 19(4):223-31; discussion 200. PubMed ID: 10376167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain-free results with sumatriptan taken at the first sign of migraine pain: 2 randomized, double-blind, placebo-controlled studies.
    Winner P; Mannix LK; Putnam DG; McNeal S; Kwong J; O'Quinn S; Richardson MS
    Mayo Clin Proc; 2003 Oct; 78(10):1214-22. PubMed ID: 14531480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Looking forward: the expanding utility of sumatriptan and naratriptan.
    Cady R
    Cephalalgia; 2001; 21 Suppl 1():35-8. PubMed ID: 11678821
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
    Géraud G; Valette C
    Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.